1. Global, regional, and national burden of Parkinson's disease, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016, the Lancet;Collaborators;Neurology,2018
2. Cannabinoid-dopamine interactions in the physiology and physiopathology of the basal ganglia;Garcia;Br. J. Pharmacol.,2016
3. [Cannabis in Parkinson's disease: hype or help?];Mainka;Fortschr. Neurol. Psychiatr.,2018
4. The therapeutic potential of cannabinoids for movement disorders, Movement disorders;Kluger;Off. J. Movement Disord. Soc.,2015
5. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement;Moher;PLoS Med.,2009